Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableLooking for participantsNCT07385599
What this trial is testing

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Lifetech Scientific (Shenzhen) Co., Ltd. 10
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Not applicableNot Yet RecruitingNCT04956978
What this trial is testing

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Who this might be right for
Atrial Fibrillation
Duke University 40
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Not applicableLooking for participantsNCT04298723
What this trial is testing

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Jena University Hospital 530
Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableEnrolling By InvitationNCT07654634
What this trial is testing

Precision Antithrombotic Therapy

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)MI(Myocardial Infarction)+1 more
The Third Xiangya Hospital of Central South University 5,000
Not applicableWithdrawnNCT02153424
What this trial is testing

Early Post-marketing Study of Eliquis (Apixaban)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb
Not applicableUnknownNCT02633982
What this trial is testing

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

Who this might be right for
Atrial Fibrillation
Japan Cardiovascular Research Foundation 5,000
Post-approval studies (Phase 4)UnknownNCT03234114
What this trial is testing

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Who this might be right for
Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital with Nanjing Medical University 3,746
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT02663076
What this trial is testing

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Chronic Kidney Disease (CKD)
GWT-TUD GmbH 1,700
Not applicableStudy completedNCT05027061
What this trial is testing

Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 11,776
Not applicableActive Not RecruitingNCT05560204
What this trial is testing

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

Who this might be right for
Combined Pulsed-field Ablation (PFA)
Prince of Wales Hospital, Shatin, Hong Kong 200
Not applicableStudy completedNCT05051904
What this trial is testing

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

Who this might be right for
Coronary Artery DiseaseAtrial Fibrillation
Boehringer Ingelheim 39,357
Not applicableUnknownNCT04476147
What this trial is testing

The Impact of Frailty on Thrombosis of Elderly Patients With NVAF （FTE-NVAF）

Who this might be right for
Non-valvular Atrial Fibrillation, Elderly, Frailty, Thrombosis
Beijing Friendship Hospital 500
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Not applicableStudy completedNCT04099238
What this trial is testing

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Who this might be right for
Atrial Fibrillation
Bayer 3,739
Not applicableStudy completedNCT02631057
What this trial is testing

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,313
Not applicableUnknownNCT02356432
What this trial is testing

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

Who this might be right for
Ischemic StrokeAtrial Fibrillation Symptomatic
Tokai University 86
Next Page